Orchid Pharma Limited

BSE: 524372 NSE: BE : ORCHPHARMA
Orchid Pharma Limited - pharma in Chengalpattu, Tamil Nadu, India. FY 2026 financials and compliance.
CIN L24222TN1992PLC022994 Incorporated 01 July 1992 ROC Chennai HQ Chengalpattu, Tamil Nadu, India
Active Listed - NSE: BE : ORCHPHARMA · BSE: 524372 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹811.33 Cr
▼ 12% YoY
Computed EBITDA · FY 2026
₹76.3 Cr
▼ 47.25% YoY
Net profit · FY 2026
₹20.55 Cr
▼ 79.38% YoY
Authorised capital
₹150 Cr
Registered with MCA
Paid-up capital
₹50.72 Cr
Issued & subscribed
Open charges
₹366.5 Cr
Satisfied ₹15,354 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
1,101
Latest available

About Orchid Pharma Limited

Data last updated: 14 July 2026

Orchid Pharma Limited is a public limited company based in Chengalpattu, Tamil Nadu, India, a subsidiary of Dhanuka Laboratories Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 01 July 1992, the company has been in operation for over 34 years.

Registered with ROC Chennai under CIN L24222TN1992PLC022994. Listed on BSE: 524372 and NSE: BE : ORCHPHARMA.

Capital: an authorised share capital of ₹150 Cr and a paid-up capital of ₹50.72 Cr. Formerly known as Orchid Chemicals & Pharmaceuticals Limited. It is led by directors including Ram Gopal Agarwal and Mridul Dhanuka.

Last AGM: 20 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 121 – 128 128A – 133 138 – 151 159 – 164, Sidco Industrial Estate Alathur Chengalpattu, Tamil Nadu, India – 603110.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹811.33 Cr, a decline of 12% compared to the previous year. The net worth stands at ₹1,287.79 Cr (up 1.62% YoY). Total assets are valued at ₹1,910.91 Cr (up 13.21% YoY).

The company has a workforce of approximately 1,101 employees as per the latest available data. It operates as a subsidiary of Dhanuka Laboratories Limited. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Orchid Pharma. As per MCA filings, the company has open charges of ₹366.5 Cr and satisfied charges of ₹15,354 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orchidpharma.com.

Company Details of Orchid Pharma Limited
CIN L24222TN1992PLC022994
Registration Number 022994
Incorporation Date 01 July 1992
ROC Chennai
Listing Status Listed (BSE: 524372, NSE: BE : ORCHPHARMA)
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Dhanuka Laboratories Limited
Compliance Status Active Compliant
Key People
Manish Dhanuka Managing Director Mridul Dhanuka Whole-Time Director Ram Gopal Agarwal Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    orchidpharma.com
  • Social Media
    Locked
  • Registered Address
    Plot No 121 – 128 128A – 133 138 – 151 159 – 164, Sidco Industrial Estate Alathur Chengalpattu, Tamil Nadu, India – 603110
  • Industry
    Pharma, Drug Formulation & Development
Company report
Orchid Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Orchid Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Orchid Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Orchid Pharma Limited

Orchid Pharma Limited has one previous CIN (Corporate Identification Number): U24222TN1992PLC022994. The current CIN is L24222TN1992PLC022994, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24222TN1992PLC022994 Current
U24222TN1992PLC022994 Previous

Associated Brands with Orchid Pharma Limited

Orchid Pharma Limited operates one associated brand: Orchid Pharma. These brands represent Orchid Pharma Limited's diversified market presence and brand portfolio.

Brand Description Website
Orchid Pharma
Bulk actives, formulations, and nutraceuticals are developed and manufactured. orchidpharma.com

Business Activity of Orchid Pharma Limited

Orchid Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Orchid Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Orchid Pharma Limited

Orchid Pharma Limited is audited by Singhi and Co. (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Singhi and Co. (ICAI peer reviewed, certificate valid till 2028-08-31) FY 2026 Statement on impact of audit qualification

Board of Directors of Orchid Pharma Limited

Orchid Pharma Limited is currently managed by 8 directors, with 32 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ram Gopal Agarwal
Also directs: Orchid Bio-Pharma Limited, H D Realtors Private Limited
Director 31 Mar 2020 6 Years 4 Months Current
Mridul Dhanuka
Also directs: Dhanuka Laboratories Limited, Orbion Pharmaceuticals Private Limited, Orchid Bio-Pharma Limited and 1 more
Whole-Time Director 31 Mar 2020 6 Years 4 Months Current
Dharam Vir Director 29 Jun 2020 6 Years 1 Months Current
Tanu Singla Director 29 Jun 2020 6 Years 1 Months Current
Manoj Kumar Goyal
Also directs: People For Change Foundation
Director 29 Jun 2020 6 Years 1 Months Current
Manish Dhanuka
Also directs: Dhanuka Laboratories Limited, Orchid Bio-Pharma Limited, Dhanuka Agritech Limited and 2 more
Managing Director 31 Mar 2020 6 Years 4 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Orchid Pharma Limited FY 2026 filings available

Orchid Pharma Limited reported revenue of ₹811.33 Cr (down 12% YoY) for FY 2026.

Revenue · FY 2026
₹811.33 Cr ▼ 12%
Profit · FY 2026
₹20.55 Cr ▼ 79.38%
Computed EBITDA · FY 2026
₹76.3 Cr ▼ 47.25%
Revenue₹ Cr · Consolidated05001,000FY 2020: ₹508 Cr508FY 2020FY 2021: ₹450 Cr · -11.4% YoY450-11.4%FY 2021FY 2022: ₹560 Cr · +24.3% YoY560+24.3%FY 2022FY 2023: ₹666 Cr · +19% YoY666+19%FY 2023FY 2024: ₹819 Cr · +23% YoY819+23%FY 2024FY 2025: ₹922 Cr · +12.5% YoY922+12.5%FY 2025FY 2026: ₹811 Cr · -12% YoY811-12%FY 2026
Net Profit₹ Cr · Consolidated-150-100-50050100FY 2020: ₹131 Cr (loss)-131FY 2020FY 2021: ₹117 Cr (loss) · +11.1% YoY-117FY 2021FY 2022: ₹2 Cr (loss) · +98.3% YoY-2FY 2022FY 2023: ₹46 Cr · +2473.8% YoY46.3+2473.8%FY 2023FY 2024: ₹92 Cr · +99% YoY92.2+99%FY 2024FY 2025: ₹100 Cr · +8.1% YoY99.7+8.1%FY 2025FY 2026: ₹21 Cr · -79.4% YoY20.5-79.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹244 Cr · +33.6% YoY244+33.6%Q1'25Q2'25: ₹223 Cr · +12% YoY223+12%Q2'25Q3'25: ₹217 Cr · -1.5% YoY217-1.5%Q3'25Q4'25: ₹237 Cr · +9.4% YoY237+9.4%Q4'25Q1'26: ₹173 Cr · -29.2% YoY173-29.2%Q1'26Q2'26: ₹194 Cr · -13.1% YoY194-13.1%Q2'26Q3'26: ₹207 Cr · -4.6% YoY207-4.6%Q3'26Q4'26: ₹238 Cr · +0.1% YoY238+0.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹811.33 Cr ₹921.93 Cr ₹819.37 Cr ₹665.9 Cr ₹559.56 Cr ₹450.06 Cr ₹508.04 Cr
Other Income ₹35.17 Cr ₹27.47 Cr ₹30.86 Cr ₹19.43 Cr ₹9 Cr ₹15.23 Cr ₹24.49 Cr
Total Income ₹846.5 Cr ₹949.4 Cr ₹850.23 Cr ₹685.33 Cr ₹568.56 Cr ₹465.29 Cr ₹532.53 Cr
Cost of Materials Consumed ₹462.34 Cr ₹585.46 Cr ₹528.35 Cr ₹406.1 Cr ₹340.62 Cr ₹245.6 Cr ₹235.54 Cr
Purchases of Stock-in-Trade ₹1.69 Cr ₹2.61 Cr ₹0 ₹0 ₹0 ₹0 ₹16.68 Lakh
Changes in Inventories ₹61.85 Cr -₹43.85 Cr -₹43.89 Cr -₹21.48 Cr -₹27.06 Cr -₹17.09 Cr ₹7.58 Cr
Employee Benefit Expense ₹91.47 Cr ₹86.36 Cr ₹69.64 Cr ₹65.35 Cr ₹63.28 Cr ₹67.11 Cr ₹84.75 Cr
Finance Costs ₹13.26 Cr ₹14.54 Cr ₹16.35 Cr ₹32.23 Cr ₹32.01 Cr ₹51.34 Cr ₹4.16 Cr
Depreciation & Amortisation ₹35.45 Cr ₹34.55 Cr ₹33.24 Cr ₹54.79 Cr ₹87.02 Cr ₹108.92 Cr ₹125.92 Cr
Other Expenses ₹152.85 Cr ₹174.17 Cr ₹154.59 Cr ₹132.31 Cr ₹133.11 Cr ₹104.67 Cr ₹205.49 Cr
Total Expenses ₹818.91 Cr ₹853.84 Cr ₹758.29 Cr ₹669.29 Cr ₹628.98 Cr ₹560.54 Cr ₹663.6 Cr
Profit Before Exceptional Items & Tax ₹27.59 Cr ₹95.56 Cr ₹91.95 Cr ₹16.04 Cr -₹60.42 Cr -₹95.25 Cr -₹131.07 Cr
Exceptional Items -₹6.57 Cr ₹0 ₹0 ₹39.21 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹21.02 Cr ₹95.56 Cr ₹91.95 Cr ₹55.25 Cr -₹60.42 Cr -₹95.25 Cr -₹131.07 Cr
Total Tax Expense -₹19.16 Lakh -₹19.35 Lakh -₹3.12 Cr ₹0 ₹0 ₹0 ₹0
Net Profit ₹20.55 Cr ₹99.66 Cr ₹92.17 Cr ₹46.32 Cr -₹1.95 Cr -₹116.53 Cr -₹131.07 Cr
  attributable to Owners - - - ₹0 ₹0 - -
  attributable to NCI - - - ₹0 ₹0 - -
Other Comprehensive Income ₹89.69 Lakh -₹75.13 Lakh -₹33.72 Lakh -₹17.88 Lakh ₹1.42 Cr ₹66.47 Lakh -₹2.02 Cr
Total Comprehensive Income ₹21.44 Cr ₹98.91 Cr ₹91.83 Cr ₹46.14 Cr -₹52.82 Lakh -₹115.87 Cr -₹133.09 Cr
EBITDA (computed) ₹76.3 Cr ₹144.65 Cr ₹141.54 Cr ₹103.05 Cr ₹58.61 Cr ₹65 Cr -₹99.04 Lakh
Basic EPS ₹4.05 ₹19.65 ₹19.06 ₹13.01 ₹-0.48 ₹-28.55 ₹-32.11
Diluted EPS ₹4.05 ₹19.65 ₹19.06 ₹13.01 ₹-0.48 ₹-28.55 ₹-32.11
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,910.91 Cr ₹1,687.91 Cr ₹1,553.87 Cr ₹1,225.21 Cr
Non-current Assets ₹1,227.01 Cr ₹880.5 Cr ₹763.12 Cr ₹724.2 Cr
Current Assets ₹683.61 Cr ₹807.42 Cr ₹790.75 Cr ₹501.01 Cr
Property, Plant & Equipment ₹613.22 Cr ₹631.59 Cr ₹618.92 Cr ₹572.71 Cr
Inventories ₹256.41 Cr ₹326.37 Cr ₹264.23 Cr ₹228.74 Cr
Trade Receivables ₹263.87 Cr ₹241.83 Cr ₹195.55 Cr ₹215.19 Cr
Cash & Equivalents ₹7.01 Cr ₹21.11 Cr ₹3.6 Cr ₹22.6 Cr
Equity (Net Worth) ₹1,287.79 Cr ₹1,267.29 Cr ₹1,169.47 Cr ₹688.65 Cr
Equity Share Capital ₹50.72 Cr ₹50.72 Cr ₹50.72 Cr ₹40.82 Cr
Borrowings (Non-current) ₹327.73 Cr ₹131.64 Cr ₹120.43 Cr ₹148.84 Cr
Borrowings (Current) ₹29.75 Cr ₹42.6 Cr ₹14.05 Cr ₹182.51 Cr
Total Debt (computed) ₹357.48 Cr ₹174.24 Cr ₹134.48 Cr ₹331.35 Cr
Current Liabilities ₹278.97 Cr ₹285.57 Cr ₹259.97 Cr ₹371.89 Cr
Total Liabilities ₹623.13 Cr ₹420.63 Cr ₹384.41 Cr ₹536.56 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹101.2 Cr ₹19.22 Cr ₹125.99 Cr ₹18.58 Cr ₹88.95 Cr
Investing Cash Flow -₹285.27 Cr -₹26.93 Cr -₹312.03 Cr -₹31.46 Cr ₹116.46 Cr
Financing Cash Flow ₹169.98 Cr ₹25.22 Cr ₹167.04 Cr ₹31.17 Cr -₹216.8 Cr
Capital Expenditure ₹383.58 Cr ₹150.11 Cr -₹64.81 Cr ₹84.91 Cr ₹14.4 Cr
Free Cash Flow (computed) -₹282.39 Cr -₹130.89 Cr ₹61.18 Cr -₹66.33 Cr ₹74.55 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹14.1 Cr ₹17.51 Cr -₹19 Cr ₹18.29 Cr -₹11.39 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹237.61 Cr ₹207.27 Cr ₹193.52 Cr ₹172.93 Cr ₹237.48 Cr ₹217.34 Cr ₹222.7 Cr ₹244.41 Cr ₹217.1 Cr ₹220.59 Cr ₹198.76 Cr ₹182.92 Cr
Other Income ₹7.34 Cr ₹5.61 Cr ₹10.77 Cr ₹11.45 Cr ₹3.9 Cr ₹8.49 Cr ₹7.52 Cr ₹7.57 Cr ₹13.36 Cr ₹7.62 Cr ₹8.36 Cr ₹1.89 Cr
Total Income ₹244.95 Cr ₹212.88 Cr ₹204.3 Cr ₹184.38 Cr ₹241.38 Cr ₹225.83 Cr ₹230.22 Cr ₹251.98 Cr ₹230.46 Cr ₹228.21 Cr ₹207.11 Cr ₹184.81 Cr
Cost of Materials Consumed ₹120.95 Cr ₹118.97 Cr ₹112.27 Cr ₹110.16 Cr ₹136.94 Cr ₹142.02 Cr ₹153.72 Cr ₹152.77 Cr ₹156.47 Cr ₹135.62 Cr ₹117.86 Cr ₹118.41 Cr
Purchases of Stock-in-Trade ₹47.59 Lakh ₹25 Lakh ₹17.34 Lakh ₹78.79 Lakh ₹1.24 Cr ₹1.37 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹29.93 Cr ₹23.93 Cr ₹20.07 Cr -₹12.08 Cr -₹17.24 Lakh -₹18.6 Cr -₹22.56 Cr -₹2.52 Cr -₹28.34 Cr -₹13.68 Cr ₹4.47 Cr -₹6.34 Cr
Employee Benefit Expense ₹20.88 Cr ₹24.13 Cr ₹24.85 Cr ₹21.61 Cr ₹22.24 Cr ₹22.06 Cr ₹20.06 Cr ₹22 Cr ₹17.57 Cr ₹19.14 Cr ₹17.56 Cr ₹16.22 Cr
Finance Costs ₹3.09 Cr ₹3.18 Cr ₹3.73 Cr ₹3.26 Cr ₹3.92 Cr ₹3.8 Cr ₹3.33 Cr ₹3.5 Cr ₹3.47 Cr ₹3.54 Cr ₹3.8 Cr ₹5.55 Cr
Depreciation & Amortisation ₹8.87 Cr ₹9.03 Cr ₹8.9 Cr ₹8.65 Cr ₹8.87 Cr ₹8.61 Cr ₹8.63 Cr ₹8.44 Cr ₹8.42 Cr ₹9.27 Cr ₹7.84 Cr ₹7.71 Cr
Other Expenses ₹38.51 Cr ₹38.43 Cr ₹37.64 Cr ₹38.28 Cr ₹49.24 Cr ₹44.13 Cr ₹41.14 Cr ₹39.66 Cr ₹42.49 Cr ₹44.12 Cr ₹35.55 Cr ₹32.49 Cr
Total Expenses ₹222.7 Cr ₹217.91 Cr ₹207.63 Cr ₹170.67 Cr ₹222.28 Cr ₹203.38 Cr ₹204.32 Cr ₹223.86 Cr ₹200.08 Cr ₹198.01 Cr ₹187.09 Cr ₹174.03 Cr
Profit Before Exceptional Items & Tax ₹22.25 Cr -₹5.03 Cr -₹3.33 Cr ₹13.71 Cr ₹19.09 Cr ₹22.45 Cr ₹25.9 Cr ₹28.12 Cr ₹30.38 Cr ₹30.19 Cr ₹20.02 Cr ₹10.78 Cr
Exceptional Items ₹53.92 Lakh -₹7.11 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹22.79 Cr -₹12.15 Cr -₹3.33 Cr ₹13.71 Cr ₹19.09 Cr ₹22.45 Cr ₹25.9 Cr ₹28.12 Cr ₹30.38 Cr ₹30.19 Cr ₹20.02 Cr ₹10.78 Cr
Total Tax Expense ₹17,000 ₹0 ₹0 ₹0 -₹3.94 Lakh ₹0 ₹0 -₹15.41 Lakh -₹3.12 Cr ₹0 ₹0 ₹0
Net Profit ₹23.78 Cr -₹12.61 Cr -₹5.72 Cr ₹14.91 Cr ₹22.29 Cr ₹20.78 Cr ₹27.24 Cr ₹29.35 Cr ₹32.96 Cr ₹29.43 Cr ₹19.8 Cr ₹9.4 Cr
  attributable to Owners - - - ₹0 - ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0
  attributable to NCI - - - ₹0 - ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0
Other Comprehensive Income ₹88.2 Lakh ₹56.42 Lakh -₹39.45 Lakh -₹15.48 Lakh ₹1.67 Cr -₹80.14 Lakh -₹1.49 Cr -₹12.44 Lakh ₹1.6 Cr -₹64.7 Lakh -₹1.24 Cr -₹5.82 Lakh
Total Comprehensive Income ₹24.66 Cr -₹12.05 Cr -₹6.12 Cr ₹14.76 Cr ₹23.96 Cr ₹19.97 Cr ₹25.74 Cr ₹29.23 Cr ₹34.56 Cr ₹28.78 Cr ₹18.57 Cr ₹9.35 Cr
EBITDA (computed) ₹34.21 Cr ₹7.17 Cr ₹9.3 Cr ₹25.62 Cr ₹31.88 Cr ₹34.85 Cr ₹37.85 Cr ₹40.06 Cr ₹42.28 Cr ₹43.01 Cr ₹31.67 Cr ₹24.03 Cr
Basic EPS ₹4.69 ₹-2.49 ₹-1.13 ₹2.94 ₹4.40 ₹4.10 ₹5.37 ₹5.79 ₹6.81 ₹6.18 ₹4.30 ₹1.85
Diluted EPS ₹4.69 ₹-2.49 ₹-1.13 ₹2.94 ₹4.40 ₹4.10 ₹5.37 ₹5.79 ₹6.81 ₹6.18 ₹4.30 ₹1.85
Latest 12 quarters shown of 23 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹811.33 Cr ₹921.93 Cr ₹819.37 Cr ₹665.9 Cr ₹556.97 Cr ₹450.7 Cr ₹505.45 Cr
Other Income ₹55.24 Cr ₹31.93 Cr ₹30.39 Cr ₹19.43 Cr ₹9 Cr ₹6.48 Cr ₹24.49 Cr
Total Income ₹866.57 Cr ₹953.86 Cr ₹849.76 Cr ₹685.33 Cr ₹565.98 Cr ₹457.17 Cr ₹529.94 Cr
Cost of Materials Consumed ₹462.34 Cr ₹585.46 Cr ₹528.35 Cr ₹406.1 Cr ₹336.8 Cr ₹244.96 Cr ₹234.24 Cr
Purchases of Stock-in-Trade ₹1.69 Cr ₹2.61 Cr ₹0 ₹0 ₹0 ₹0 ₹16.68 Lakh
Changes in Inventories ₹61.85 Cr -₹43.85 Cr -₹43.89 Cr -₹21.48 Cr -₹22.73 Cr -₹15.69 Cr ₹5.83 Cr
Employee Benefit Expense ₹88.14 Cr ₹86.36 Cr ₹69.64 Cr ₹65.35 Cr ₹60.21 Cr ₹64.4 Cr ₹81.48 Cr
Finance Costs ₹13.24 Cr ₹14.54 Cr ₹16.33 Cr ₹32.23 Cr ₹32.01 Cr ₹51.34 Cr ₹4.16 Cr
Depreciation & Amortisation ₹35.56 Cr ₹34.44 Cr ₹33.22 Cr ₹54.79 Cr ₹87.02 Cr ₹108.9 Cr ₹125.9 Cr
Other Expenses ₹151.98 Cr ₹167.81 Cr ₹154.59 Cr ₹132.31 Cr ₹125.44 Cr ₹99.14 Cr ₹227.99 Cr
Total Expenses ₹814.79 Cr ₹847.37 Cr ₹758.23 Cr ₹669.29 Cr ₹618.75 Cr ₹553.04 Cr ₹679.77 Cr
Profit Before Exceptional Items & Tax ₹51.78 Cr ₹106.48 Cr ₹91.52 Cr ₹16.04 Cr -₹52.77 Cr -₹95.87 Cr -₹149.84 Cr
Exceptional Items -₹6.57 Cr ₹0 ₹0 ₹39.21 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹45.21 Cr ₹106.48 Cr ₹91.52 Cr ₹55.25 Cr -₹52.77 Cr -₹95.87 Cr -₹149.84 Cr
Total Tax Expense ₹0 ₹0 -₹3.23 Cr ₹0 ₹0 ₹0 ₹0
Net Profit ₹45.21 Cr ₹106.48 Cr ₹94.75 Cr ₹54.19 Cr -₹4.81 Cr -₹117.15 Cr -₹149.84 Cr
Other Comprehensive Income ₹89.69 Lakh -₹75.13 Lakh -₹33.72 Lakh -₹17.88 Lakh ₹1.42 Cr ₹66.47 Lakh -₹2.02 Cr
Total Comprehensive Income ₹46.1 Cr ₹105.73 Cr ₹94.41 Cr ₹54.01 Cr -₹3.38 Cr -₹116.49 Cr -₹151.86 Cr
EBITDA (computed) ₹100.58 Cr ₹155.46 Cr ₹141.07 Cr ₹103.05 Cr ₹66.26 Cr ₹64.36 Cr -₹19.78 Cr
Basic EPS ₹8.91 ₹20.99 ₹19.59 ₹13.54 ₹-1.18 ₹-28.70 ₹-36.71
Diluted EPS ₹8.91 ₹20.99 ₹19.59 ₹13.54 ₹-1.18 ₹-28.70 ₹-36.71
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,750.12 Cr ₹1,696.58 Cr ₹1,552.2 Cr ₹1,223.26 Cr
Non-current Assets ₹1,114.13 Cr ₹910.19 Cr ₹769.91 Cr ₹729.46 Cr
Current Assets ₹635.99 Cr ₹786.39 Cr ₹782.29 Cr ₹493.79 Cr
Property, Plant & Equipment ₹591.69 Cr ₹612.12 Cr ₹615.12 Cr ₹572.67 Cr
Inventories ₹256.41 Cr ₹326.37 Cr ₹264.23 Cr ₹228.74 Cr
Trade Receivables ₹263.87 Cr ₹241.83 Cr ₹189.37 Cr ₹211.91 Cr
Cash & Equivalents ₹1.24 Cr ₹15.87 Cr ₹29.47 Lakh ₹18.31 Cr
Equity (Net Worth) ₹1,370.15 Cr ₹1,324.05 Cr ₹1,218.32 Cr ₹731.96 Cr
Equity Share Capital ₹50.72 Cr ₹50.72 Cr ₹50.72 Cr ₹40.82 Cr
Borrowings (Non-current) ₹178.62 Cr ₹131.64 Cr ₹120.21 Cr ₹148.84 Cr
Borrowings (Current) ₹95.81 Lakh ₹42.6 Cr ₹14.05 Cr ₹182.51 Cr
Total Debt (computed) ₹179.58 Cr ₹174.24 Cr ₹134.26 Cr ₹331.35 Cr
Current Liabilities ₹182.8 Cr ₹237.47 Cr ₹209.67 Cr ₹326.63 Cr
Total Liabilities ₹379.96 Cr ₹372.53 Cr ₹333.89 Cr ₹491.3 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹118.64 Cr ₹27.48 Cr ₹130.73 Cr ₹13.39 Cr ₹89.57 Cr
Investing Cash Flow -₹125.37 Cr -₹37.35 Cr -₹315.81 Cr -₹26.7 Cr ₹112.93 Cr
Financing Cash Flow -₹7.9 Cr ₹25.44 Cr ₹167.07 Cr ₹31.17 Cr -₹216.8 Cr
Capital Expenditure ₹165.77 Cr ₹68.54 Cr ₹55.15 Cr ₹84.55 Cr ₹14.4 Cr
Free Cash Flow (computed) -₹47.13 Cr -₹41.06 Cr ₹75.57 Cr -₹71.16 Cr ₹75.16 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹14.63 Cr ₹15.58 Cr -₹18.01 Cr ₹17.86 Cr -₹14.3 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹237.61 Cr ₹207.27 Cr ₹193.52 Cr ₹172.93 Cr ₹237.48 Cr ₹217.34 Cr ₹222.7 Cr ₹244.41 Cr ₹217.1 Cr ₹220.59 Cr ₹198.76 Cr ₹182.92 Cr
Other Income ₹13.3 Cr ₹10.59 Cr ₹15.43 Cr ₹15.93 Cr ₹6.26 Cr ₹9.94 Cr ₹7.96 Cr ₹7.77 Cr ₹12.88 Cr ₹7.44 Cr ₹8.18 Cr ₹1.89 Cr
Total Income ₹250.9 Cr ₹217.86 Cr ₹208.95 Cr ₹188.86 Cr ₹243.74 Cr ₹227.28 Cr ₹230.66 Cr ₹252.18 Cr ₹229.99 Cr ₹228.03 Cr ₹206.94 Cr ₹184.81 Cr
Cost of Materials Consumed ₹120.95 Cr ₹118.97 Cr ₹112.27 Cr ₹110.16 Cr ₹136.94 Cr ₹142.02 Cr ₹153.72 Cr ₹152.77 Cr ₹156.47 Cr ₹135.62 Cr ₹117.86 Cr ₹118.41 Cr
Purchases of Stock-in-Trade ₹47.59 Lakh ₹25 Lakh ₹17.34 Lakh ₹78.79 Lakh ₹1.24 Cr ₹1.37 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹29.93 Cr ₹23.93 Cr ₹20.07 Cr -₹12.08 Cr -₹17.24 Lakh -₹18.6 Cr -₹22.56 Cr -₹2.52 Cr -₹28.34 Cr -₹13.68 Cr ₹4.47 Cr -₹6.34 Cr
Employee Benefit Expense ₹19.59 Cr ₹22.88 Cr ₹24.05 Cr ₹21.61 Cr ₹22.24 Cr ₹22.06 Cr ₹20.69 Cr ₹21.37 Cr ₹17.57 Cr ₹18.66 Cr ₹17.19 Cr ₹16.22 Cr
Finance Costs ₹3.08 Cr ₹3.17 Cr ₹3.73 Cr ₹3.26 Cr ₹3.98 Cr ₹3.79 Cr ₹3.3 Cr ₹3.47 Cr ₹3.45 Cr ₹3.54 Cr ₹3.8 Cr ₹5.55 Cr
Depreciation & Amortisation ₹9.15 Cr ₹8.97 Cr ₹8.79 Cr ₹8.65 Cr ₹8.76 Cr ₹8.61 Cr ₹8.63 Cr ₹8.44 Cr ₹8.4 Cr ₹9.27 Cr ₹7.84 Cr ₹7.71 Cr
Other Expenses ₹37.66 Cr ₹38.4 Cr ₹37.64 Cr ₹38.27 Cr ₹42.89 Cr ₹44.13 Cr ₹41.27 Cr ₹39.53 Cr ₹42.49 Cr ₹44.07 Cr ₹35.53 Cr ₹32.49 Cr
Total Expenses ₹220.84 Cr ₹216.57 Cr ₹206.72 Cr ₹170.66 Cr ₹215.89 Cr ₹203.37 Cr ₹205.04 Cr ₹223.08 Cr ₹200.03 Cr ₹197.48 Cr ₹186.7 Cr ₹174.03 Cr
Profit Before Exceptional Items & Tax ₹30.06 Cr ₹1.29 Cr ₹2.23 Cr ₹18.2 Cr ₹27.85 Cr ₹23.91 Cr ₹25.63 Cr ₹29.1 Cr ₹29.96 Cr ₹30.55 Cr ₹20.24 Cr ₹10.78 Cr
Exceptional Items ₹53.92 Lakh -₹7.11 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹30.6 Cr -₹5.82 Cr ₹2.23 Cr ₹18.2 Cr ₹27.85 Cr ₹23.91 Cr ₹25.63 Cr ₹29.1 Cr ₹29.96 Cr ₹30.55 Cr ₹20.24 Cr ₹10.78 Cr
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹3.23 Cr ₹0 ₹0 ₹0
Net Profit ₹30.6 Cr -₹5.82 Cr ₹2.23 Cr ₹18.2 Cr ₹27.85 Cr ₹23.91 Cr ₹25.63 Cr ₹29.1 Cr ₹33.19 Cr ₹30.55 Cr ₹20.24 Cr ₹10.78 Cr
Other Comprehensive Income ₹88.2 Lakh ₹56.42 Lakh -₹39.45 Lakh -₹15.48 Lakh ₹1.67 Cr -₹80.14 Lakh -₹1.49 Cr -₹12.44 Lakh ₹1.6 Cr -₹64.7 Lakh -₹1.24 Cr -₹5.82 Lakh
Total Comprehensive Income ₹31.49 Cr -₹5.26 Cr ₹1.84 Cr ₹18.04 Cr ₹29.52 Cr ₹23.1 Cr ₹24.13 Cr ₹28.98 Cr ₹34.79 Cr ₹29.9 Cr ₹19.01 Cr ₹10.72 Cr
EBITDA (computed) ₹42.29 Cr ₹13.43 Cr ₹14.75 Cr ₹30.11 Cr ₹40.59 Cr ₹36.3 Cr ₹37.55 Cr ₹41.02 Cr ₹41.81 Cr ₹43.35 Cr ₹31.88 Cr ₹24.03 Cr
Basic EPS ₹6.03 ₹-1.15 ₹0.44 ₹3.59 ₹5.49 ₹4.71 ₹5.05 ₹5.74 ₹6.86 ₹6.42 ₹4.40 ₹2.64
Diluted EPS ₹6.03 ₹-1.15 ₹0.44 ₹3.59 ₹5.49 ₹4.71 ₹5.05 ₹5.74 ₹6.86 ₹6.42 ₹4.40 ₹2.64
Latest 12 quarters shown of 23 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Orchid Pharma Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Orchid Pharma Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 69.84%, foreign institutional investors hold 0.87%, domestic institutional investors hold 20.25%, retail and other public shareholders hold 9.05% of Orchid Pharma Limited. The company had 35,118 shareholders on record.

Promoters: 69.84%DII (Domestic Institutional): 20.25%FII (Foreign Institutional): 0.87%Retail & Others: 9.05%
Mar 2026
QUARTER
69.84% Promoters
20.25% DII (Domestic Institutional)
0.87% FII (Foreign Institutional)
9.05% Retail & Others
Promoter holding - history
Now 69.84% · Mar 2026High 98.07% · Dec 2020Low 69.84% · Dec 2023
68%76%84%92%100%Mar 2020Dec 2021Mar 2023Jun 2024Sep 2025Mar 2020: 98.04%Dec 2020: 98.07%Mar 2021: 98.07%Jun 2021: 90.00%Sep 2021: 90.00%Dec 2021: 90.00%Mar 2022: 90.00%Jun 2022: 89.96%Sep 2022: 89.96%Dec 2022: 89.96%Mar 2023: 89.96%Jun 2023: 72.40%Sep 2023: 72.40%Dec 2023: 69.84%Mar 2024: 69.84%Jun 2024: 69.84%Sep 2024: 69.84%Dec 2024: 69.84%Mar 2025: 69.84%Jun 2025: 69.84%Sep 2025: 69.84%Dec 2025: 69.84%Mar 2026: 69.84%98.07%69.84%69.84%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters69.84%69.84%69.84%69.84%69.84%69.84%
Public30.16%30.16%30.16%30.16%30.16%30.16%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Promoters69.84%69.84%69.84%89.96%90.00%98.07%98.04%
Public30.16%30.16%30.16%10.04%10.01%1.93%1.97%
Promoter change (YoY, %pts)+0.00+0.00-20.12-0.04-8.07+0.03-

Board & Governance of Orchid Pharma Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Orchid Pharma Limited has 8 directors - 4 independent and 2 executive. The board is chaired by Ram Gopal Agarwal.

DirectorPositionOn board sinceListed boards
Ram Gopal Agarwal Non-Executive - Non Independent Director · Chairperson 2020-03-31 1
Manish Dhanuka Executive Director · MD 2020-03-31 2
Mridul Dhanuka Executive Director 2020-03-31 1
Arjun Dhanuka Non-Executive - Non Independent Director 2023-10-20 1
Dharam Vir Non-Executive - Independent Director 2020-06-29 1
Manoj Kumar Goyal Non-Executive - Independent Director 2020-06-29 1
Shubha Singh Non-Executive - Independent Director 2024-05-23 3
Tanu Singla Non-Executive - Independent Director 2020-06-29 1
Board Committees
CommitteeMembers
Audit Committee Manoj Kumar Goyal (Chairperson), Tanu Singla, Mridul Dhanuka
Nomination and remuneration committee Dharam Vir (Chairperson), Arjun Dhanuka, Manoj Kumar Goyal, Shubha Singh
Stakeholders Relationship Committee Dharam Vir (Chairperson), Manoj Kumar Goyal, Tanu Singla
Risk Management Committee Dharam Vir (Chairperson), Manish Dhanuka, Mridul Dhanuka, Sunil Kumar Gupta, A Chandrasekar
Corporate Social Responsibility Committee Dharam Vir (Chairperson), Manish Dhanuka, Mridul Dhanuka
Banking Finance and Operations Committee Manish Dhanuka (Chairperson), Mridul Dhanuka

Group Structure of Orchid Pharma Limited

Orchid Pharma Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Orchid Pharma Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Orchid Bio-Pharma Limited U24230TN2022PLC150784 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Orchid Pharma Limited

Open charges
₹366.5 Cr
Satisfied charges
₹15,354 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹291.50 Cr
Yes Bank Limited₹75.00 Cr
Latest charge details
DateLenderAmountStatus
17 Jul 2025 Hdfc Bank Limited ₹142.5 Cr Open
27 Aug 2022 Yes Bank Limited ₹75 Cr Open
15 Nov 2021 Hdfc Bank Limited ₹149 Cr Open
02 Aug 2023 Hdfc Bank Limited ₹50 Cr Satisfied
06 Jul 2020 Others ₹229.67 Cr Satisfied

Total charge records: 179 View all charges

Employees and EPFO Compliance at Orchid Pharma Limited

Orchid Pharma Limited has a workforce of 1,101 employees as of Nov 28, 2025.

Employee count
1,101
Active EPFO establishments
1
Employee growth
3.19%
Premium access

Employee and EPFO history for Orchid Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Orchid Pharma Limited

Premium access

GST registrations and filing compliance for Orchid Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Orchid Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Orchid Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Orchid Pharma Limited

Premium access

MSME payment history for Orchid Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Orchid Pharma Limited

Premium access

Corporate group structure for Orchid Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Orchid Pharma Limited

Premium access

MCA filings and documents for Orchid Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Orchid Pharma Limited

Charges
08 Oct 2025
A charge with Hdfc Bank Limited of Rs. 142.50 Cr registered on 17 Jul 2025 with Charge ID 101132171 was modified on 08 Oct 2025.
Activity
20 Sep 2025
Orchid Pharma Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Charges
17 Jul 2025
A charge with Hdfc Bank Limited amounted to Rs. 142.50 Cr with Charge ID 101132171 was registered on 17 Jul 2025.
Activity
31 Mar 2025
Orchid Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Directors
23 May 2024
Shubha Singh was appointed as a Director on 23 May 2024 & has been associated with this company since 2 years 3 months.
Charges
10 Jan 2024
A charge with Yes Bank Limited of Rs. 75.00 Cr registered on 27 Aug 2022 with Charge ID 100615515 was modified on 10 Jan 2024.

Recent News on Orchid Pharma Limited

Frequently Asked Questions about Orchid Pharma Limited

Orchid Pharma Limited is an active public limited company in the pharma sector based in Chengalpattu, Tamil Nadu, India. It was incorporated on 01 July 1992 (34+ years old) and is registered under CIN L24222TN1992PLC022994. Listed on BSE: 524372 and NSE: BE : ORCHPHARMA. The company has 1,101 employees.

Orchid Pharma Limited reported revenue of ₹811.33 Cr for FY 2026 (down 12% YoY) based on consolidated NSE filings.

The current directors of Orchid Pharma Limited are:

The primary industry of Orchid Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Orchid Pharma Limited is listed on both BSE (code: 524372) and NSE (symbol: BE : ORCHPHARMA).

Orchid Pharma Limited can be reached at the registered office: Plot No 121 – 128 128A – 133 138 – 151 159 – 164, Sidco Industrial Estate Alathur Chengalpattu, Tamil Nadu, India – 603110, or through the website orchidpharma.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available